5Wiley SR,Schooley K,Smolak PJ,et al.Identification and characterization of a new member of the TNF family that induces apoptosis.Immunity,1995.3(6):673-682.
6Yee L,Fanale M,Dimick K.et al.A phase IB safety and pharmacokinetic(PK)study of recombinant human Apo2L/TRAIL in combination with rituximab in patients with low-grade non-Hodgkin lymphoma.J Clini Oncolo,2007.25(18):8078.
7Pitti RM,Marsters SA,Ruppert S,et al.Induction of apoptosis by Apo-2 ligand,a new member of the tumor necrosis factor cytokine family.J Biol Chem,1996,271(22):12687-12690.
8Schneider P.Production of recombinant TRAIL and TRAIL receptor.Fc chimeric proteins.Methods Enzymol,2000,322:325-345.
9Ganten TM.Koschny R,Sykora J,et al.Preclinical differentiation between apparently safe and potentially hepatotoxic applications of TRAIL either alone or in combination with chemotherapeutic drugs.Clin Cancer Res,2006,12(8):2640-2646.
10MACKAY F, KALLED S L. TNF ligands and receptors in autoimmunity: an update[J]. Curr Opin Immunol, 2002, 14(6) : 783-790.